Modulation of HERG Potassium Channels by Extracellular Magnesium and Quinidine
- 1 February 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 33 (2), 181-185
- https://doi.org/10.1097/00005344-199902000-00002
Abstract
Torsades de pointes is a polymorphic ventricular arrhythmia resulting from congenital or drug-induced (acquired) QT prolongation. Pharmacologic suppression of repolarizing potassium currents is one mechanism causing the acquired long QT (LQT) syndrome. Recent studies have linked mutations in a gene encoding a potassium channel subunit (HERG) to the LQT syndrome. Clinical experience indicates that intravenous magnesium sulfate is effective in reversing torsades de pointes, but the molecular basis of this effect is not understood. This study was designed to investigate the effects of extracellular magnesium (Mg2+) on HERG potassium currents. HERG potassium channels were expressed in Xenopus oocytes and in a human cell line and were examined by voltage-clamp methods. Extracellular Mg2+ (0.3-10 mM) caused a concentration-dependent shift in the membrane-potential dependence of HERG channel opening, causing a reduction in K+ current. This effect was much greater than that observed in another human delayed rectifier K+ channel, hKv1.5, suggesting a specific interaction with the HERG channel. Quinidine is an antiarrhythmic drug that also causes torsades de pointes under certain conditions. Quinidine (3 μM) inhibited HERG currents expressed in oocytes by 32.1 ± 3.2% (n = 5), whereas 1 μM quinidine inhibited HERG currents in tsA201 cells by 75.8 ± 2.4% (n = 12). Increasing extracellular Mg2+ did not relieve the inhibition by quinidine, but caused additional suppression. These results indicate that extracellular Mg2+ exerts a direct action on HERG potassium channels, resulting in suppression of outward repolarizing potassium current. It is concluded that modulation of this important K+ current is not the mechanism by which intravenous magnesium terminates drug-induced LQT and torsades de pointes. Potent suppression of HERG channel current by quinidine, compared with that of IKs and INa, is a likely contributor to torsades de pointes arrhythmias.Keywords
This publication has 47 references indexed in Scilit:
- A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytesThe Journal of Physiology, 1997
- The inward rectification mechanism of the HERG cardiac potassium channelNature, 1996
- Risks and Benefits of Antiarrhythmic TherapyNew England Journal of Medicine, 1994
- Locus heterogeneity of autosomal dominant long QT syndrome.Journal of Clinical Investigation, 1993
- Molecular Genetics and Ventricular ArrhythmiasNew England Journal of Medicine, 1992
- Magnesium Therapy in Ventricular ArrhythmiasPacing and Clinical Electrophysiology, 1990
- Magnesium sulphate for torsade de pointes in a patient with congenital long QT syndromeInternational Journal of Cardiology, 1990
- Clinical features of arrhythmia aggravation by antiarrhythmic drugs and their implications for basic mechanismsDrug Development Research, 1990
- Treatment of torsade de pointes with intravenous magnesiumThe American Journal of Cardiology, 1989
- Magnesium therapy for torsades de pointesThe American Journal of Cardiology, 1984